Table 2.

Impact of patient characteristics and treatment on hematuria incidence within three years post-SBRT

Factors	Univariate analysis	Multivariate analysis
Age	0.651	0.419
Race	0.523	0.917
D’Amico’s Risk Groups	0.805	0.122
Prostate Volume	0.022†	0.081
Initial PSA	0.546	0.804
Androgen Deprivation Therapy	0.507	0.507
Procedure for BPH prior to RT	0.002†	<0.0001*
Initial AUA	0.508	0.897
α1A Antagonist usage	0.082	0.008*
Charlson Comorbidity Index	0.787	0.101
Anticoagulant usage	0.321	0.435

†significant in univariate analysis, *significant in multivarariate analysis.